News
Learn how Mounjaro (tirzepatide) may reverse pre-diabetes in young adults in India, its benefits, and why early action is key.
For adults with type 2 diabetes and obesity, glucagon-like peptide 1 receptor agonists (GLP-1 RAs) are associated with a lower risk for dementia, stroke, and all-cause mortality compared with other ...
In India’s rapidly urbanising metros, from Delhi to Bengaluru, life moves fast. Unfortunately, so do lifestyle-related ...
Men receiving tirzepatide showed greater reductions in body weight and waist circumference and improvements in erectile ...
Mounjaro kick-started my weight loss, but true success came from hard work, persistence and changing bad habits ...
Landmark trials have shown that GLP-1 receptor agonists, originally developed for diabetes and weight loss, also provide ...
In a recent study published in Life Metabolism, researchers at Fudan University report that even after stopping the anti-obesity drug tirzepatide, ...
Obesity has become a global epidemic, contributing to a host of chronic health conditions such as type 2 diabetes, hypertension, and cardiovascular ...
12h
Oprah Daily on MSNCan Combining GLP-1s and Hormone Therapy Boost Weight Loss? A New Study Shows Significant ResultsMenopausal hormone treatment (MHT) might indirectly help with weight loss by improving sleep and redistributing abdominal fat ...
13h
Flow Space on MSNIs This the Secret to Maintaining a Healthy Weight in Menopause?Menopause can feel like one big balancing act. Between managing your hormone levels and symptoms like hot flashes, night ...
Clinical trial data review on weight-loss drugs reveals weight regain patterns post-medication discontinuation, impacting weight management strategies.
Baseline BMI may play a significant role in improving exercise capacity, body weight and BP among patients with HF with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results